Ads
related to: lca stock price
Search results
With 65% institutional ownership, Landcadia Holdings IV, Inc. (NASDAQ:LCA) is a favorite amongst the...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of Landcadia Holdings IV, Inc. (NASDAQ:LCA), it is...
General Electric (GE), HAL Sign MOU to Make Jet Engines for IAF
Zacks via Yahoo Finance· 11 months agoGeneral Electric (GE) Arm, GE Aerospace signs an MOU with HAL to co-produce GE's F414 engines in...
14 Small-Cap Stocks with High Potential
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we will take a look at the 14 small-cap stocks with high potential. You can skip this part and go to 5 Small-Cap Stocks with High...
3 Stocks Under $5 Ready to Outpace the Market
InvestorPlace via Yahoo Finance· 2 months agoFinding hidden jewels in the stock market ready for explosive development — especially stocks under $5 — is like finding hidden treasure on the ocean...
DuPont (DD) Attains Full Conversion to Low-GWP Styrofoam
Zacks via Yahoo Finance· 6 months agoDuPont de Nemours Inc. DD said that all Styrofoam Brand XPS insulation manufacturing sites in North...
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 month agoOcugen (OCGN) is expected to provide updates regarding the developmental program of its lead...
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks via Yahoo Finance· 2 days agoOcugen, Inc. OCGN is having a phenomenal run in the year so far. Shares of the company have...
Ocugen Inc (OCGN) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ...
GuruFocus.com via Yahoo Finance· 3 weeks agoResearch and Development Expenses: $6.8 million for Q1 2024, down from $10.2 million in Q1 2023. General and Administrative Expenses: $6.4 million for Q1 2024, decreased from $8.3 million in ...
Here’s Why CoreCard Corporation (CCRD) Detracted in Q4
Insider Monkey via Yahoo Finance· 4 months agoLong Cast Advisers, an investment management firm, released its fourth quarter 2023 investor letter,...
Ocugen Highlights Interim Data From Gene Therapy Study For Genetic Vision Loss Disorder
Benzinga via Yahoo Finance· 1 year agoOcugen Inc (NASDAQ: OCGN) announced preliminary data among retinitis pigmentosa (RP) participants...